Grabarek, B., Krzaczyński, J., Strzałka‐Mrozik, B., Wcisło‐Dziadecka, D., & Gola, J. (2019). The influence of ustekinumab on expression of STAT1, STAT3, STAT4, SOCS2, and IL17 in patients with psoriasis and in a control. Dermatologic therapy, 32(5), e13029-n/a. https://doi.org/10.1111/dth.13029
Chicago Style (17th ed.) CitationGrabarek, Beniamin, Jakub Krzaczyński, Barbara Strzałka‐Mrozik, Dominika Wcisło‐Dziadecka, and Joanna Gola. "The Influence of Ustekinumab on Expression of STAT1, STAT3, STAT4, SOCS2, and IL17 in Patients with Psoriasis and in a Control." Dermatologic Therapy 32, no. 5 (2019): e13029-n/a. https://doi.org/10.1111/dth.13029.
MLA (9th ed.) CitationGrabarek, Beniamin, et al. "The Influence of Ustekinumab on Expression of STAT1, STAT3, STAT4, SOCS2, and IL17 in Patients with Psoriasis and in a Control." Dermatologic Therapy, vol. 32, no. 5, 2019, pp. e13029-n/a, https://doi.org/10.1111/dth.13029.